APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Factor VIII Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Factor VIII Concentrate Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchHuman Factor VIII Concentrate Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Factor VIII Concentrate Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Human Factor VIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Factor VIII Concentrate Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Factor VIII Concentrate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Factor VIII Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Factor VIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Factor VIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Factor VIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Factor VIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Factor VIII Concentrate include Shandong Taibang Biological Products, Shanghai Xinxing Medicine, Shanghai Raas Corp, Novo Nordisk A/S, Grifols, Pfizer, Hualan Biological, Bayer and SinoCell Tech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Factor VIII Concentrate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Factor VIII Concentrate, also provides the sales of main regions and countries. Of the upcoming market potential for Human Factor VIII Concentrate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Factor VIII Concentrate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Factor VIII Concentrate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Factor VIII Concentrate sales, projected growth trends, production technology, application and end-user industry.

Human Factor VIII Concentrate Segment by Company

Shandong Taibang Biological Products

Shanghai Xinxing Medicine

Shanghai Raas Corp

Novo Nordisk A/S

Grifols

Pfizer

Hualan Biological

Bayer

SinoCell Tech

Shire (Baxter)

Octapharma

NovoNordisk

GC Pharma

CSL

Biogen

Human Factor VIII Concentrate Segment by Type

Blood Extraction

Recombine

Human Factor VIII Concentrate Segment by Application

Von Willebrand's Disease

Congenital Coagulation Factor VIII Deficiency

Acquired Factor VIII Deficiency

Human Factor VIII Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Factor VIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Factor VIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Factor VIII Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Factor VIII Concentrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Factor VIII Concentrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Factor VIII Concentrate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Factor VIII Concentrate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Extraction Major Manufacturers Table 3. Recombine Major Manufacturers Table 4. Global Human Factor VIII Concentrate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Von Willebrand's Disease Major Manufacturers Table 6. Congenital Coagulation Factor VIII Deficiency Major Manufacturers Table 7. Acquired Factor VIII Deficiency Major Manufacturers Table 8. Human Factor VIII Concentrate Industry Trends Table 9. Human Factor VIII Concentrate Industry Drivers Table 10. Human Factor VIII Concentrate Industry Opportunities and Challenges Table 11. Human Factor VIII Concentrate Industry Restraints Table 12. Global Human Factor VIII Concentrate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Human Factor VIII Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Human Factor VIII Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Human Factor VIII Concentrate Revenue Market Share by Region (2021-2026) Table 16. Global Human Factor VIII Concentrate Revenue Market Share by Region (2027-2032) Table 17. Global Human Factor VIII Concentrate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Human Factor VIII Concentrate Sales by Region (2021-2026) & (k units) Table 19. Global Human Factor VIII Concentrate Sales by Region (2027-2032) & (k units) Table 20. Global Human Factor VIII Concentrate Sales Market Share by Region (2021-2026) Table 21. Global Human Factor VIII Concentrate Sales Market Share by Region (2027-2032) Table 22. Global Human Factor VIII Concentrate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Human Factor VIII Concentrate Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Human Factor VIII Concentrate Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2021-2026) Table 26. Global Human Factor VIII Concentrate Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Human Factor VIII Concentrate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Human Factor VIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Human Factor VIII Concentrate Manufacturers, Product Type & Application Table 30. Global Human Factor VIII Concentrate Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Human Factor VIII Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Human Factor VIII Concentrate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Human Factor VIII Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Human Factor VIII Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Human Factor VIII Concentrate Revenue Market Share by Type (2021-2026) Table 37. Global Human Factor VIII Concentrate Revenue Market Share by Type (2027-2032) Table 38. Global Human Factor VIII Concentrate Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 40. Global Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 41. Global Human Factor VIII Concentrate Sales Market Share by Type (2021-2026) Table 42. Global Human Factor VIII Concentrate Sales Market Share by Type (2027-2032) Table 43. Global Human Factor VIII Concentrate Price by Type (2021-2026) & (US$/unit) Table 44. Global Human Factor VIII Concentrate Price by Type (2027-2032) & (US$/unit) Table 45. Global Human Factor VIII Concentrate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Human Factor VIII Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Human Factor VIII Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Human Factor VIII Concentrate Revenue Market Share by Application (2021-2026) Table 49. Global Human Factor VIII Concentrate Revenue Market Share by Application (2027-2032) Table 50. Global Human Factor VIII Concentrate Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 52. Global Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 53. Global Human Factor VIII Concentrate Sales Market Share by Application (2021-2026) Table 54. Global Human Factor VIII Concentrate Sales Market Share by Application (2027-2032) Table 55. Global Human Factor VIII Concentrate Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Factor VIII Concentrate Price by Application (2027-2032) & (US$/unit) Table 57. Shandong Taibang Biological Products Company Information Table 58. Shandong Taibang Biological Products Business Overview Table 59. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio Table 61. Shandong Taibang Biological Products Recent Development Table 62. Shanghai Xinxing Medicine Company Information Table 63. Shanghai Xinxing Medicine Business Overview Table 64. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio Table 66. Shanghai Xinxing Medicine Recent Development Table 67. Shanghai Raas Corp Company Information Table 68. Shanghai Raas Corp Business Overview Table 69. Shanghai Raas Corp Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio Table 71. Shanghai Raas Corp Recent Development Table 72. Novo Nordisk A/S Company Information Table 73. Novo Nordisk A/S Business Overview Table 74. Novo Nordisk A/S Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio Table 76. Novo Nordisk A/S Recent Development Table 77. Grifols Company Information Table 78. Grifols Business Overview Table 79. Grifols Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Grifols Human Factor VIII Concentrate Product Portfolio Table 81. Grifols Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Pfizer Human Factor VIII Concentrate Product Portfolio Table 86. Pfizer Recent Development Table 87. Hualan Biological Company Information Table 88. Hualan Biological Business Overview Table 89. Hualan Biological Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Hualan Biological Human Factor VIII Concentrate Product Portfolio Table 91. Hualan Biological Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Bayer Human Factor VIII Concentrate Product Portfolio Table 96. Bayer Recent Development Table 97. SinoCell Tech Company Information Table 98. SinoCell Tech Business Overview Table 99. SinoCell Tech Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. SinoCell Tech Human Factor VIII Concentrate Product Portfolio Table 101. SinoCell Tech Recent Development Table 102. Shire (Baxter) Company Information Table 103. Shire (Baxter) Business Overview Table 104. Shire (Baxter) Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Shire (Baxter) Human Factor VIII Concentrate Product Portfolio Table 106. Shire (Baxter) Recent Development Table 107. Octapharma Company Information Table 108. Octapharma Business Overview Table 109. Octapharma Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Octapharma Human Factor VIII Concentrate Product Portfolio Table 111. Octapharma Recent Development Table 112. NovoNordisk Company Information Table 113. NovoNordisk Business Overview Table 114. NovoNordisk Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. NovoNordisk Human Factor VIII Concentrate Product Portfolio Table 116. NovoNordisk Recent Development Table 117. GC Pharma Company Information Table 118. GC Pharma Business Overview Table 119. GC Pharma Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. GC Pharma Human Factor VIII Concentrate Product Portfolio Table 121. GC Pharma Recent Development Table 122. CSL Company Information Table 123. CSL Business Overview Table 124. CSL Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. CSL Human Factor VIII Concentrate Product Portfolio Table 126. CSL Recent Development Table 127. Biogen Company Information Table 128. Biogen Business Overview Table 129. Biogen Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Biogen Human Factor VIII Concentrate Product Portfolio Table 131. Biogen Recent Development Table 132. North America Human Factor VIII Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Human Factor VIII Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 135. North America Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 136. North America Human Factor VIII Concentrate Sales Price by Type (2021-2026) & (US$/unit) Table 137. North America Human Factor VIII Concentrate Sales Price by Type (2027-2032) & (US$/unit) Table 138. North America Human Factor VIII Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Human Factor VIII Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 141. North America Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 142. North America Human Factor VIII Concentrate Sales Price by Application (2021-2026) & (US$/unit) Table 143. North America Human Factor VIII Concentrate Sales Price by Application (2027-2032) & (US$/unit) Table 144. North America Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Human Factor VIII Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Human Factor VIII Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 148. North America Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 149. North America Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 150. North America Human Factor VIII Concentrate Sales Price by Country (2021-2026) & (US$/unit) Table 151. North America Human Factor VIII Concentrate Sales Price by Country (2027-2032) & (US$/unit) Table 152. United States Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 153. Canada Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 154. Mexico Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 155. Europe Human Factor VIII Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Human Factor VIII Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 158. Europe Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 159. Europe Human Factor VIII Concentrate Sales Price by Type (2021-2026) & (US$/unit) Table 160. Europe Human Factor VIII Concentrate Sales Price by Type (2027-2032) & (US$/unit) Table 161. Europe Human Factor VIII Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Human Factor VIII Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 164. Europe Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 165. Europe Human Factor VIII Concentrate Sales Price by Application (2021-2026) & (US$/unit) Table 166. Europe Human Factor VIII Concentrate Sales Price by Application (2027-2032) & (US$/unit) Table 167. Europe Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Human Factor VIII Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Human Factor VIII Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. Europe Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 172. Europe Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 173. Europe Human Factor VIII Concentrate Sales Price by Country (2021-2026) & (US$/unit) Table 174. Europe Human Factor VIII Concentrate Sales Price by Country (2027-2032) & (US$/unit) Table 175. Germany Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 176. France Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 177. U.K. Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 178. Italy Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 179. Russia Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 180. Spain Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 183. Sweden Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 184. Poland Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 185. China Human Factor VIII Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 186. China Human Factor VIII Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 187. China Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 188. China Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 189. China Human Factor VIII Concentrate Sales Price by Type (2021-2026) & (US$/unit) Table 190. China Human Factor VIII Concentrate Sales Price by Type (2027-2032) & (US$/unit) Table 191. China Human Factor VIII Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 192. China Human Factor VIII Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 193. China Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 194. China Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 195. China Human Factor VIII Concentrate Sales Price by Application (2021-2026) & (US$/unit) Table 196. China Human Factor VIII Concentrate Sales Price by Application (2027-2032) & (US$/unit) Table 197. Asia Human Factor VIII Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Human Factor VIII Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 200. Asia Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 201. Asia Human Factor VIII Concentrate Sales Price by Type (2021-2026) & (US$/unit) Table 202. Asia Human Factor VIII Concentrate Sales Price by Type (2027-2032) & (US$/unit) Table 203. Asia Human Factor VIII Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Human Factor VIII Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 206. Asia Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 207. Asia Human Factor VIII Concentrate Sales Price by Application (2021-2026) & (US$/unit) Table 208. Asia Human Factor VIII Concentrate Sales Price by Application (2027-2032) & (US$/unit) Table 209. Asia Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Human Factor VIII Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Human Factor VIII Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 213. Asia Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 214. Asia Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 215. Asia Human Factor VIII Concentrate Sales Price by Country (2021-2026) & (US$/unit) Table 216. Asia Human Factor VIII Concentrate Sales Price by Country (2027-2032) & (US$/unit) Table 217. Japan Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 218. South Korea Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 219. India Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 220. Australia Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Human Factor VIII Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Human Factor VIII Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 226. SAMEA Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 227. SAMEA Human Factor VIII Concentrate Sales Price by Type (2021-2026) & (US$/unit) Table 228. SAMEA Human Factor VIII Concentrate Sales Price by Type (2027-2032) & (US$/unit) Table 229. SAMEA Human Factor VIII Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Human Factor VIII Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 232. SAMEA Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 233. SAMEA Human Factor VIII Concentrate Sales Price by Application (2021-2026) & (US$/unit) Table 234. SAMEA Human Factor VIII Concentrate Sales Price by Application (2027-2032) & (US$/unit) Table 235. SAMEA Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Human Factor VIII Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Human Factor VIII Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. SAMEA Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 240. SAMEA Human Factor VIII Concentrate Sales by Country (2027-2032) & (k units) Table 241. SAMEA Human Factor VIII Concentrate Sales Price by Country (2021-2026) & (US$/unit) Table 242. SAMEA Human Factor VIII Concentrate Sales Price by Country (2027-2032) & (US$/unit) Table 243. Brazil Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 244. Argentina Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 245. Chile Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 246. Colombia Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 247. Peru Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 249. Israel Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 250. UAE Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 251. Turkey Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 252. Iran Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 253. Egypt Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Human Factor VIII Concentrate Distributors List Table 257. Human Factor VIII Concentrate Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Human Factor VIII Concentrate Image Figure 2. Global Human Factor VIII Concentrate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Factor VIII Concentrate Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Extraction Image Figure 5. Recombine Image Figure 6. Global Human Factor VIII Concentrate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Factor VIII Concentrate Market Size Share 2021 VS 2025 VS 2032 Figure 8. Von Willebrand's Disease Image Figure 9. Congenital Coagulation Factor VIII Deficiency Image Figure 10. Acquired Factor VIII Deficiency Image Figure 11. Global Human Factor VIII Concentrate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Human Factor VIII Concentrate Revenue (2021-2032) & (US$ Million) Figure 13. Global Human Factor VIII Concentrate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Human Factor VIII Concentrate Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Human Factor VIII Concentrate Revenue Market Share by Region (2021-2032) Figure 16. Global Human Factor VIII Concentrate Sales (2021-2032) & (k units) Figure 17. Global Human Factor VIII Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Human Factor VIII Concentrate Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Human Factor VIII Concentrate Sales YoY (2021-2032) & (k units) Figure 20. Europe Human Factor VIII Concentrate Sales YoY (2021-2032) & (k units) Figure 21. China Human Factor VIII Concentrate Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Human Factor VIII Concentrate Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Human Factor VIII Concentrate Sales YoY (2021-2032) & (k units) Figure 24. Global Human Factor VIII Concentrate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Human Factor VIII Concentrate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Human Factor VIII Concentrate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Human Factor VIII Concentrate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Human Factor VIII Concentrate Revenue Market Share by Type (2021-2032) Figure 30. Global Human Factor VIII Concentrate Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Human Factor VIII Concentrate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Human Factor VIII Concentrate Sales Market Share by Type (2021-2032) Figure 33. Global Human Factor VIII Concentrate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Human Factor VIII Concentrate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Human Factor VIII Concentrate Revenue Market Share by Application (2021-2032) Figure 36. Global Human Factor VIII Concentrate Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Human Factor VIII Concentrate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Human Factor VIII Concentrate Sales Market Share by Application (2021-2032) Figure 39. North America Human Factor VIII Concentrate Revenue Share by Type (2021-2032) Figure 40. North America Human Factor VIII Concentrate Sales Share by Type (2021-2032) Figure 41. North America Human Factor VIII Concentrate Revenue Share by Application (2021-2032) Figure 42. North America Human Factor VIII Concentrate Sales Share by Application (2021-2032) Figure 43. North America Human Factor VIII Concentrate Revenue Share by Country (2021-2032) Figure 44. North America Human Factor VIII Concentrate Sales Share by Country (2021-2032) Figure 45. Europe Human Factor VIII Concentrate Revenue Share by Type (2021-2032) Figure 46. Europe Human Factor VIII Concentrate Sales Share by Type (2021-2032) Figure 47. Europe Human Factor VIII Concentrate Revenue Share by Application (2021-2032) Figure 48. Europe Human Factor VIII Concentrate Sales Share by Application (2021-2032) Figure 49. Europe Human Factor VIII Concentrate Revenue Share by Country (2021-2032) Figure 50. Europe Human Factor VIII Concentrate Sales Share by Country (2021-2032) Figure 51. China Human Factor VIII Concentrate Revenue Share by Type (2021-2032) Figure 52. China Human Factor VIII Concentrate Sales Share by Type (2021-2032) Figure 53. China Human Factor VIII Concentrate Revenue Share by Application (2021-2032) Figure 54. China Human Factor VIII Concentrate Sales Share by Application (2021-2032) Figure 55. Asia Human Factor VIII Concentrate Revenue Share by Type (2021-2032) Figure 56. Asia Human Factor VIII Concentrate Sales Share by Type (2021-2032) Figure 57. Asia Human Factor VIII Concentrate Revenue Share by Application (2021-2032) Figure 58. Asia Human Factor VIII Concentrate Sales Share by Application (2021-2032) Figure 59. Asia Human Factor VIII Concentrate Revenue Share by Country (2021-2032) Figure 60. Asia Human Factor VIII Concentrate Sales Share by Country (2021-2032) Figure 61. SAMEA Human Factor VIII Concentrate Revenue Share by Type (2021-2032) Figure 62. SAMEA Human Factor VIII Concentrate Sales Share by Type (2021-2032) Figure 63. SAMEA Human Factor VIII Concentrate Revenue Share by Application (2021-2032) Figure 64. SAMEA Human Factor VIII Concentrate Sales Share by Application (2021-2032) Figure 65. SAMEA Human Factor VIII Concentrate Revenue Share by Country (2021-2032) Figure 66. SAMEA Human Factor VIII Concentrate Sales Share by Country (2021-2032) Figure 67. Human Factor VIII Concentrate Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Factor VIII Concentrate Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Extraction
  • Recombine
Applications
  • Von Willebrand's Disease
  • Congenital Coagulation Factor VIII Deficiency
  • Acquired Factor VIII Deficiency
Companies covered
  • Shandong Taibang Biological Products
  • Shanghai Xinxing Medicine
  • Shanghai Raas Corp
  • Novo Nordisk A/S
  • Grifols
  • Pfizer
  • Hualan Biological
  • Bayer
  • SinoCell Tech
  • Shire (Baxter)
  • Octapharma
  • NovoNordisk
  • GC Pharma
  • CSL
  • Biogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Factor VIII Concentrate Market by Type
  3. 1.2.1 Global Human Factor VIII Concentrate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Extraction
  5. 1.2.3 Recombine
  6. 1.3 Human Factor VIII Concentrate Market by Application
  7. 1.3.1 Global Human Factor VIII Concentrate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Von Willebrand's Disease
  9. 1.3.3 Congenital Coagulation Factor VIII Deficiency
  10. 1.3.4 Acquired Factor VIII Deficiency
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Human Factor VIII Concentrate Market Dynamics
  1. 2.1 Human Factor VIII Concentrate Industry Trends
  2. 2.2 Human Factor VIII Concentrate Industry Drivers
  3. 2.3 Human Factor VIII Concentrate Industry Opportunities and Challenges
  4. 2.4 Human Factor VIII Concentrate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Factor VIII Concentrate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Factor VIII Concentrate Revenue by Region
  3. 3.2.1 Global Human Factor VIII Concentrate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Factor VIII Concentrate Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Factor VIII Concentrate Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Factor VIII Concentrate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Factor VIII Concentrate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Factor VIII Concentrate Sales by Region
  9. 3.4.1 Global Human Factor VIII Concentrate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Factor VIII Concentrate Sales by Region (2021-2026)
  11. 3.4.3 Global Human Factor VIII Concentrate Sales by Region (2027-2032)
  12. 3.4.4 Global Human Factor VIII Concentrate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Factor VIII Concentrate Revenue by Manufacturers
  2. 4.1.1 Global Human Factor VIII Concentrate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Factor VIII Concentrate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Factor VIII Concentrate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Factor VIII Concentrate Sales by Manufacturers
  6. 4.2.1 Global Human Factor VIII Concentrate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Factor VIII Concentrate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Factor VIII Concentrate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Factor VIII Concentrate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Factor VIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Factor VIII Concentrate Manufacturers, Product Type & Application
  13. 4.7 Global Human Factor VIII Concentrate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Factor VIII Concentrate Market CR5 and HHI
  16. 4.8.2 2025 Human Factor VIII Concentrate Tier 1, Tier 2, and Tier 3
5 Human Factor VIII Concentrate Market by Type
  1. 5.1 Global Human Factor VIII Concentrate Revenue by Type
  2. 5.1.1 Global Human Factor VIII Concentrate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Factor VIII Concentrate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Factor VIII Concentrate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Factor VIII Concentrate Sales by Type
  6. 5.2.1 Global Human Factor VIII Concentrate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Factor VIII Concentrate Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Factor VIII Concentrate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Factor VIII Concentrate Price by Type
6 Human Factor VIII Concentrate Market by Application
  1. 6.1 Global Human Factor VIII Concentrate Revenue by Application
  2. 6.1.1 Global Human Factor VIII Concentrate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Factor VIII Concentrate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Factor VIII Concentrate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Factor VIII Concentrate Sales by Application
  6. 6.2.1 Global Human Factor VIII Concentrate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Factor VIII Concentrate Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Factor VIII Concentrate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Factor VIII Concentrate Price by Application
7 Company Profiles
  1. 7.1 Shandong Taibang Biological Products
  2. 7.1.1 Shandong Taibang Biological Products Company Information
  3. 7.1.2 Shandong Taibang Biological Products Business Overview
  4. 7.1.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio
  6. 7.1.5 Shandong Taibang Biological Products Recent Developments
  7. 7.2 Shanghai Xinxing Medicine
  8. 7.2.1 Shanghai Xinxing Medicine Company Information
  9. 7.2.2 Shanghai Xinxing Medicine Business Overview
  10. 7.2.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio
  12. 7.2.5 Shanghai Xinxing Medicine Recent Developments
  13. 7.3 Shanghai Raas Corp
  14. 7.3.1 Shanghai Raas Corp Company Information
  15. 7.3.2 Shanghai Raas Corp Business Overview
  16. 7.3.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio
  18. 7.3.5 Shanghai Raas Corp Recent Developments
  19. 7.4 Novo Nordisk A/S
  20. 7.4.1 Novo Nordisk A/S Company Information
  21. 7.4.2 Novo Nordisk A/S Business Overview
  22. 7.4.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio
  24. 7.4.5 Novo Nordisk A/S Recent Developments
  25. 7.5 Grifols
  26. 7.5.1 Grifols Company Information
  27. 7.5.2 Grifols Business Overview
  28. 7.5.3 Grifols Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Grifols Human Factor VIII Concentrate Product Portfolio
  30. 7.5.5 Grifols Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Human Factor VIII Concentrate Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Hualan Biological
  38. 7.7.1 Hualan Biological Company Information
  39. 7.7.2 Hualan Biological Business Overview
  40. 7.7.3 Hualan Biological Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hualan Biological Human Factor VIII Concentrate Product Portfolio
  42. 7.7.5 Hualan Biological Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Human Factor VIII Concentrate Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 SinoCell Tech
  50. 7.9.1 SinoCell Tech Company Information
  51. 7.9.2 SinoCell Tech Business Overview
  52. 7.9.3 SinoCell Tech Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 SinoCell Tech Human Factor VIII Concentrate Product Portfolio
  54. 7.9.5 SinoCell Tech Recent Developments
  55. 7.10 Shire (Baxter)
  56. 7.10.1 Shire (Baxter) Company Information
  57. 7.10.2 Shire (Baxter) Business Overview
  58. 7.10.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shire (Baxter) Human Factor VIII Concentrate Product Portfolio
  60. 7.10.5 Shire (Baxter) Recent Developments
  61. 7.11 Octapharma
  62. 7.11.1 Octapharma Company Information
  63. 7.11.2 Octapharma Business Overview
  64. 7.11.3 Octapharma Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Octapharma Human Factor VIII Concentrate Product Portfolio
  66. 7.11.5 Octapharma Recent Developments
  67. 7.12 NovoNordisk
  68. 7.12.1 NovoNordisk Company Information
  69. 7.12.2 NovoNordisk Business Overview
  70. 7.12.3 NovoNordisk Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 NovoNordisk Human Factor VIII Concentrate Product Portfolio
  72. 7.12.5 NovoNordisk Recent Developments
  73. 7.13 GC Pharma
  74. 7.13.1 GC Pharma Company Information
  75. 7.13.2 GC Pharma Business Overview
  76. 7.13.3 GC Pharma Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 GC Pharma Human Factor VIII Concentrate Product Portfolio
  78. 7.13.5 GC Pharma Recent Developments
  79. 7.14 CSL
  80. 7.14.1 CSL Company Information
  81. 7.14.2 CSL Business Overview
  82. 7.14.3 CSL Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 CSL Human Factor VIII Concentrate Product Portfolio
  84. 7.14.5 CSL Recent Developments
  85. 7.15 Biogen
  86. 7.15.1 Biogen Company Information
  87. 7.15.2 Biogen Business Overview
  88. 7.15.3 Biogen Human Factor VIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Biogen Human Factor VIII Concentrate Product Portfolio
  90. 7.15.5 Biogen Recent Developments
8 North America
  1. 8.1 North America Human Factor VIII Concentrate Market Size by Type
  2. 8.1.1 North America Human Factor VIII Concentrate Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Factor VIII Concentrate Sales by Type (2021-2032)
  4. 8.1.3 North America Human Factor VIII Concentrate Price by Type (2021-2032)
  5. 8.2 North America Human Factor VIII Concentrate Market Size by Application
  6. 8.2.1 North America Human Factor VIII Concentrate Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Factor VIII Concentrate Sales by Application (2021-2032)
  8. 8.2.3 North America Human Factor VIII Concentrate Price by Application (2021-2032)
  9. 8.3 North America Human Factor VIII Concentrate Market Size by Country
  10. 8.3.1 North America Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Factor VIII Concentrate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Factor VIII Concentrate Market Size by Type
  2. 9.1.1 Europe Human Factor VIII Concentrate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Factor VIII Concentrate Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Factor VIII Concentrate Price by Type (2021-2032)
  5. 9.2 Europe Human Factor VIII Concentrate Market Size by Application
  6. 9.2.1 Europe Human Factor VIII Concentrate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Factor VIII Concentrate Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Factor VIII Concentrate Price by Application (2021-2032)
  9. 9.3 Europe Human Factor VIII Concentrate Market Size by Country
  10. 9.3.1 Europe Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Factor VIII Concentrate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Factor VIII Concentrate Market Size by Type
  2. 10.1.1 China Human Factor VIII Concentrate Revenue by Type (2021-2032)
  3. 10.1.2 China Human Factor VIII Concentrate Sales by Type (2021-2032)
  4. 10.1.3 China Human Factor VIII Concentrate Price by Type (2021-2032)
  5. 10.2 China Human Factor VIII Concentrate Market Size by Application
  6. 10.2.1 China Human Factor VIII Concentrate Revenue by Application (2021-2032)
  7. 10.2.2 China Human Factor VIII Concentrate Sales by Application (2021-2032)
  8. 10.2.3 China Human Factor VIII Concentrate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Factor VIII Concentrate Market Size by Type
  2. 11.1.1 Asia Human Factor VIII Concentrate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Factor VIII Concentrate Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Factor VIII Concentrate Price by Type (2021-2032)
  5. 11.2 Asia Human Factor VIII Concentrate Market Size by Application
  6. 11.2.1 Asia Human Factor VIII Concentrate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Factor VIII Concentrate Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Factor VIII Concentrate Price by Application (2021-2032)
  9. 11.3 Asia Human Factor VIII Concentrate Market Size by Country
  10. 11.3.1 Asia Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Factor VIII Concentrate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Factor VIII Concentrate Market Size by Type
  2. 12.1.1 SAMEA Human Factor VIII Concentrate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Factor VIII Concentrate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Factor VIII Concentrate Price by Type (2021-2032)
  5. 12.2 SAMEA Human Factor VIII Concentrate Market Size by Application
  6. 12.2.1 SAMEA Human Factor VIII Concentrate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Factor VIII Concentrate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Factor VIII Concentrate Price by Application (2021-2032)
  9. 12.3 SAMEA Human Factor VIII Concentrate Market Size by Country
  10. 12.3.1 SAMEA Human Factor VIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Factor VIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Factor VIII Concentrate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Factor VIII Concentrate Value Chain Analysis
  2. 13.1.1 Human Factor VIII Concentrate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Factor VIII Concentrate Production Mode & Process
  6. 13.2 Human Factor VIII Concentrate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Factor VIII Concentrate Distributors
  9. 13.2.3 Human Factor VIII Concentrate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst